COVID-19 molecular testing in korea: Practical essentials and answers from experts based on experiences of emergency use authorization assays

N/ACitations
Citations of this article
77Readers
Mendeley users who have this article in their library.

Abstract

Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Early detection of COVID-19 and immediate isolation of infected patients from the naive population are important to prevent further pandemic spread of the infection. Real-time reverse transcription (RT)-PCR to detect SARS-CoV-2 RNA is currently the most reliable diagnostic method for confirming COVID-19 worldwide. Guidelines for clinical laboratories on the COVID-19 diagnosis have been recently published by Korean Society for Laboratory Medicine and the Korea Centers for Disease Control and Prevention. However, these formal guidelines do not address common practical laboratory issues related to COVID-19 real-time RT-PCR testing and their solutions. Therefore, this guideline is intended as a practical and technical supplement to the “Guidelines for Laboratory Diagnosis of COVID-19 in Korea”.

Cite

CITATION STYLE

APA

Sung, H., Roh, K. H., Hong, K. H., Seong, M. W., Ryoo, N., Kim, H. S., … Yoo, C. K. (2020, November 1). COVID-19 molecular testing in korea: Practical essentials and answers from experts based on experiences of emergency use authorization assays. Annals of Laboratory Medicine. Seoul National University, Institute for Cognitive Science. https://doi.org/10.3343/alm.2020.40.6.439

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free